NCT06538779 Sonographic Examination of Median Nerve Variations
| NCT ID | NCT06538779 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yunus Burak Bayır |
| Condition | Carpal Tunnel Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 129 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2025-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 129 participants in total. It began in 2024-09-01 with a primary completion date of 2025-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to evaluate the prevalence of bifid median nerve in patients diagnosed with carpal tunnel syndrome (CTS) and whether it has a higher prevalence in CTS patients than in asymptomatic individuals, and to evaluate the characteristics of the bifid median nerve found and whether median nerve variations are predisposing factors in the development of CTS.
Eligibility Criteria
Inclusion Criteria: * Having typical Carpal Tunnel Sydnrome symptoms lasting longer than 3 months * Carpal tunnel syndrome diagnosed with EMG * Being a male/female \>18 years of age Exclusion Criteria: * History of polyneuropathy, brachial plexopathy, thoracic outlet syndrome, or surgery in the wrist area * Presence of inflammatory arthritis, hypothyroidism, pregnancy, rheumatological disorders, diabetes mellitus * Presence of peripheral vascular disease
Contact & Investigator
Başak MANSIZ KAPLAN, assoc. prof.
STUDY CHAIR
Ankara Etlik City Hospital
Frequently Asked Questions
Who can join the NCT06538779 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Carpal Tunnel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06538779 currently recruiting?
Yes, NCT06538779 is actively recruiting participants. Contact the research team at yunusburakbayir@gmail.com for enrollment information.
Where is the NCT06538779 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06538779 clinical trial?
NCT06538779 is sponsored by Yunus Burak Bayır. The principal investigator is Başak MANSIZ KAPLAN, assoc. prof. at Ankara Etlik City Hospital. The trial plans to enroll 129 participants.